Search
Filters
Clear All
  • 1
  • 7

Phase

  • 1
  • 6
  • 8

Found 8 nicole-barrow trials

A listing of nicole-barrow medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Real-Time Monitoring of Patient Centered Outcomes in English And Non-English-Speaking Patients

J
Jordan Holmes
18-100 years
All genders
An unmet need remains to provide culturally and linguistically competent healthcare both at the legislative and implementation levels. Our hypothesis is that capturing PROs in patients’ native language would overcome the barriers inherent to physician-patient language discordance 
Learn More

Evaluating Different Methods of Circulating Tumor DNA Quantification in Oncology Patients

T
Tim Lautenschlaeger, MD
18-100 years
Healthy Volunteer
All genders
This study aims to invent a test that can see tiny pieces from people with cancer (specifically DNA from a person’s cancer) in blood and urine better than tests that can currently be done. In the future, this test can possibly be used to find a small cancer before other …
Learn More

TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer

R
Richard Zellars, MD
40-100 years
Female
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy.
Learn More

Evaluating a 3D Printed Oral Stent Device with Suction for Oral Cancer RT

M
Mark Langer, MD
18-100 years
All genders
A foam bite is the standard device used to hold the tongue in place during radiation treatment of cancers of the tongue. There is no device currently available to fix the tongue in place and remove oral secretions (i.e. saliva) through suction tubing attached to the stent. We wish to see …
Learn More

Phase 1/2 Study of Modern Immunotherapy in BCG-Relapsing Urothelial Carcinoma of the Bladder (ADAPT)

N
Nabil Adra, MD
18-100 years
All genders
The main purpose of this phase 1 trial is to show that durvalumab is safe when given alone, in combination with BCG treatments, and in combination with radiation therapy. The overall goal of this trial is to see if the risk of your cancer coming back can be decreased with …
Learn More

Testing the Addition of Chemotherapy Drug, Cisplatin, to Usual Radiation Therapy for Patients with Head and Neck Cancer

G
Greg Durm, MD
18-100 years
All genders
Phase 2
Interventional
The purpose of this study is to compare two treatment approaches that are currently used after surgery for head and neck cancer. One approach is to administer radiation therapy alone. A second approach is to administer radiation therapy along with the chemotherapy drug, cisplatin.
Learn More

Randomized Phase II/III Trial of Radiotherapy with Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy with Concurrent Cetuximab in Patients with Stage III-IVB Head and Neck Cancer with a Contraindication to Cisplatin

G
Greg Durm, MD
18-100 years
All genders
The purpose of this study is to compare any good and bad effects of usual radiation plus the study treatment, MEDI4736 (durvalumab), to the usual therapy of radiation plus cetuximab in patients with head and neck cancer who cannot take the drug cisplatin.
Learn More

A Dose Escalation Study of Intensity Modulated Total Marrow Irradiation (IMRT-TMI) with Fludarabine as a Myeloablative Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Relapsed and Refractory Hematologic Malignancies

N
Naoyuki Saito, MD
18-65 years
All genders
The purposes of this study are to: (1) find the most effective dose of a new type of radiation therapy called total marrow irradiation (TMI) that will be given with the conditioning chemotherapy, fludarabine, to prepare patients for allogeneic hematopoietic stem cell transplantation (Allo-HSCT); and (2) see if utilization of …
Learn More